![Megan Baldwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Baldwin
Director/Board Member at
RACURA ONCOLOGY LTD
Net worth: 2 029 $ as of 30/06/2026
Profile
Megan Baldwin was the founder of Opthea Ltd., founded in 1984, and served as Chief Innovation Officer from 2024 to 2025.
Current jobs include Deputy Chairman at AusBiotech Ltd. since 2017, Director at Anaxis Pharma Pty Ltd., Director at Gertrude Biomedical Pty Ltd., Independent Non-Executive Director at Racura Oncology Ltd. starting in 2025, and Member at the Australian Institute of Co. Directors.
Former jobs include Chief Executive Officer at Opthea Pty Ltd. from 2012 to 2015, Independent Non-Executive Director at Invex Therapeutics Ltd. from 2021 to 2024, and Member at Roche Group Pty Ltd. Education includes a doctorate from the University of Melbourne.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 05/09/2025 | 195,299 ( 0.01% ) | 2 029 $ | 30/06/2026 | |
RACURA ONCOLOGY LTD -.--% | 25/11/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Megan Baldwin active positions
| Companies | Position | Start |
|---|---|---|
| RACURA ONCOLOGY LTD | Director/Board Member | 01/01/2025 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Director/Board Member | 14/12/2017 |
Anaxis Pharma Pty Ltd.
 Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Director/Board Member | - |
Former positions of Megan Baldwin
| Companies | Position | End |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Chief Executive Officer | 27/10/2023 |
| INVEX THERAPEUTICS LTD | Director/Board Member | 30/06/2024 |
Opthea Pty Ltd. | Chief Executive Officer | 01/12/2015 |
Roche Group Pty Ltd. | Corporate Officer/Principal | - |
Training of Megan Baldwin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Roche Group Pty Ltd. | |
Opthea Pty Ltd. | |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Invex Therapeutics Ltd.
 Invex Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company and develops therapeutics for neurological conditions | Health Technology |
Anaxis Pharma Pty Ltd.
Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Health Technology |
- Stock Market
- Insiders
- Megan Baldwin
